Tuesday 17th September 2024
15:00
–
20:00
Registration
17:00
–
18:30
Executive Committee Meeting - room ASNI
18:30
–
19:30
Council Meeting
20:30
President's Dinner
Wednesday 18th September 2024
08:00
–
19:00
Registration
08:45
–
09:00
President’s Welcome Speech
President of ISBD
M. Schirmer (Austria)
Presidente of the Conference
Z. Tazi Mezalek (Morocco)
President of Moroccan Society of Internal Medicine
M. Adnaoui (Morocco)
09:00
–
09:35
Special Lecture Netosis in auto-inflammation
Chairs : M. Schirmer (Austria), M. Adnaoui (Morocco)
09:35
–
11:20
Scientific Session 1: Basic Science
Chairs : M. Schirmer (Austria), M. Adnaoui (Morocco)
09:35
–
09:55
Immunopathogenesis of Behçet’s disease
PM. Van Hagen (Netherlands)
09:55
–
10:15
NET’s in Behçet’s disease
A. LeJoncour (France)
10:15
–
10:35
Microbiome and microbes in Behçet’s disease
A. Bettiol (Italy)
10:35
–
11:20
Oral presentations - Session 1
11:15
–
11:45
Coffee Break
11:45
–
13:25
Scientific Session 2: Epidemiology & Genetics
Chairman : L. Guillevin (France), H. El Kabli (Morocco)
11:45
–
12:05
Epidemiologic and genetic contribution to the phenotype of Behçet’s disease
A. Gul (Turkey)
12:05
–
12:25
Registries in Behçet’s disease
L. Cantarini (Italy)
12:25
–
12:45
Pathogenesis of non-infectious uveitis elucidated by recent findings
P. Haris (UK)
12:45
–
13:25
Oral presentations - Session 2
13:30
–
14:30
Symposium * – Lunch box
With the institutional support of ABBVIE Morocco
Management of ocular involvement in Behcet's disease
14:45
–
16:30
Scientific Session 3: Ocular Disease
Chairman : A. Moutaoukil (Morocco), D. Saadoun (France)
14:45
–
15:05
What is and what is not ocular Behçet’s disease
M. Khairallah (Tunisia)
15:05
–
15:25
Evaluation of activity in ocular Behçet’s disease
B. Bodaghi (France)
15:25
–
15:45
Treatment of ocular Behçet’s disease in 2024
I. Tugal-Tutkun (Turkey)
15:45
–
16:30
Oral presentations - Session 3
16:30
–
17:00
Coffee Break
17:00
–
18:45
Scientific Session 4: Neurologic Disease
Chairman : B. Weschler (France), F. Belahcen (Morocco)
17:00
–
17:20
Neurological involvement by Behçet’s syndrome: clinical features, diagnosis.
D. Kidd (UK)
17:20
–
17:40
Treatment and outcome in neuro-Behçet
D. Saadoun (France)
17:40
–
18:00
Unmet needs in neuro-Behçet
D. Kidd (UK)
18:00
–
18:45
Oral presentations - Session 4
19:00
–
19:30
General assembly
19:00
Poster tour
20:30
Welcome Cocktail
Thursday 19th September 2024
07:45
–
08:45
Meet the expert:clinical cases of
- Neurological : Room Menara
F . Belahsen (Morocco)
,
Wechsler (France)
- Ocular : Room Ourika
O . Berbich (Morocco)
,
FZ. Alaoui (Morocco)
- Vascular : Room Asni
Z. Tazi Mezalek (Morocco)
,
G. Emmi (Italy)
- Mucocutaneous : Room Imlil 1
C. Zouboulis (Germany)
- Articular Room Imlil 2
JAM. van Laar (Netherlands)
,
L. Essaadouni (Morocco)
09:00
–
09:45
Special Opening Lecture
Chairman : P. Cacoub (France), Z. Tazi Mezalek (Morocco)
From Behçet’s disease to canker sores: the genetic architecture of autoinflammation
D. Kastner (USA)
09:45
–
11:15
Scientific Session 5: Vascular Behçet
Chairman : Z. Tazi Mezalek (Morocco), P. Cacoub (France)
09:45
–
10:05
Clinical vascular phenotype
G. Emmi (Italy)
10:05
–
10:25
Treatment of vascular disease
G. Hatemi (Turkey)
10:25
–
10:45
Pulmonary and cardiac Behcet’s disease
E. Seyahi (Turkey)
10:45
–
10:55
Assessment of asymptomatic vascular disease with imaging in Behcet's: controversial issues
H. Direskeneli (Turkey)
10:55
–
11:30
Oral presentations - Session 5
11:30
–
11:50
Coffee Break
11:50
–
13:30
Scientific Session 6: Muco-cutaneous and articular Behçet’s disease
Chairman : F. Allali (Morocco), A. Altenburg (Germany)
11:50
–
12:10
Skin lesions in Adamantiades Behcet’s disease
C. Zouboulis (Germany)
12:10
–
12:30
Oral health in Behçet’s disease
F. Fortune (UK)
12:30
–
12:50
Gastrointestinal manifestations of Behçet’s disease: diagnosis and treatment
JH. Cheon (Korea)
12:50
–
13:10
Musculoskeletal disorders: what is and what is not Behçet's disease
K. Echchilali (Morocco)
13:10
–
13:35
Oral presentations - Session 6
13:50
–
14:40
Symposium * – Lunch box
With the institutional support of Afric-Phar Morocco
Venous thrombosis in Behcet's disease : what is the optimal treatment ?
14:45
–
18:50
Scientific Session 7 - Diagnosis and outcomes in Behçet’s disease
Chairman : K. Bouayad (Morocco), M. Smiti (Tunisia)
14:45
–
15:05
Developing outcome measures in Behcet’s disease
Y. Yazici (USA)
15:05
–
15:25
Classification or diagnostic criteria in Behçet’s disease?
F. Alibaz (Turkey)
15:25
–
15:45
Paediatric Behçet’s disease: diagnosis and classification
I. Koné-Paut (France)
15:45
–
16:05
Treat to target objective in Behcet’s disease. Is it realistic?
G. Hatemi (Turkey)
16:05
–
16:50
Oral presentations - Session 7
16:50
–
17:15
Coffee Break
17:15
–
18:45
Poster tour
20:30
Congress diner
Friday 20th September 2024
07:45
–
08:45
Meet The experts : clinical cases
- Neurologic : Room Menara
K. Serraj (Morocco)
,
M. Smiti (Tunisia)
,
N. Kissani (Morocco)
- Ocular : Room Ourika
H. Harmouche (Morocco)
,
M. Khairallah (Tunisia)
- Vascular : Room Asni
B. Lekehel (Morocco)
,
P. Cacoub (France)
- Mucocutaneous : Room Imlil 1
M. Bourkia (Morocco)
,
A. Altenburg (Germany)
- Gastroenterology : Room Imlil 2
JH. Cheon (Korea)
,
M. Benazzouz (Morocco)
- Pediatrics : Room Ouirgane
K. Bouayad (Morocco)
,
I. Koné-Paut (France)
09:00
–
09:40
Special Lecture : Behcet's diseace in 2030
Chairmain : F. Fortune (UK), FZ. Alaoui (Morocco).
09:45
–
11:15
Scientific Session 8 : Old drugs/new drugs in Behcet's disease
Chairman: N. Hajjaj Hassouni (Morocco), G. Hatemi (Turkey)
09:45
–
10:05
Is there still a place for immunosuppressant’s in Behçet’s disease
Y. Yazici (USA)
10:05
–
10:25
Anti-TNF alpha, the new “corticosteroids” in Behçet’s disease ?
P. Sfikakis (Greece)
10:25
–
10:45
Interleukins and anti-interleukins in Behçet’s disease
JAM. van Laar (Netherlands)
10:45
–
11:30
Oral presentations - Session 8
11:30
–
12:00
Announcement of Posters prizes
Closure of the 20th ICBD, welcome to the 21th ICBD
Patients program of International Conference of Behçet Disease
R. Talarico (Italy), L. Essaadouni (Morocco)
* online registration required
Wednesday 18th September 2024
18:30
–
19:30
Meeting room - ASNI
18:30
–
18:35
Introduction to the first day
M. Schirmer (Austria)
,
R. Talarico (Italy)
,
L. Essaadouni (Morocco)
18:30
–
18:50
Empowerment and patient education in Behcet’s disease
D. Martinello (italy)
,
R. Talarico (Italy)
18:50
–
19:05
Quality of life in Behcet’s disease
F. Fortune (UK)
19:05
–
20:20
The unmet needs in Behçet’s community: the patients perspective
R. Talarico (Italy)
,
D. Martinello (italy)
19:20
–
19:39
Discussion
Thursday 19th September 2024
18:30
–
19:30
Meeting room ASNI
18:30
–
18:35
Introduction to the second day
R. Talarico (Italy)
,
L. Essaadouni (Morocco)
18:35
–
18:50
New treatments in Behçet’s disease
JAM. van Laar (Netherlands)
18:50
–
19:05
Self-management in Behçet’s disease
K. Lebbar (Morocco)
,
A. Sebban
19:05
–
19:25
Round Table on adherence to therapy
L. Essaadouni (Morocco)
,
R. Talarico (Italy)
,
F. Fortune (UK)
,
JAM. van Laar (Netherlands)
,
K. Lebbar (Morocco)
,
A. Sebban
19:00
–
19:30
Discussion
Sponsor Diamant
abbvie
Janssen
AstraZeneca
AFRIC-PHAR
Sponsor Platiunum
NOVARTIS
axess pharma
hikma
SOTHEMA
sanofi
Sponsor Gold
AMGEN
AMANYS
GSK
Boehringer Ingelheim
PHARMA 5
PHARMAPROM
Laprophan
Gilead
Sponsor Silver
Roche
Biocon
SERVIER
COOPER PHARMA
Health
InQure
VIATRIS
ASPEN
Generation Santé
IBERMA
Versalya
technimede